Manchester Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Manchester Capital Management LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $2.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$2.3M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 13,270 | $1.8M |
| INSMINSMED Inc | 1,017 | $166K |
| SNYSanofi | 1,607 | $77K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,096 | $60K |
| REGNREGENERON PHARMACEUTICALS, INC. | 46 | $36K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 86 | $28K |
| ABVXAbivax SA | 200 | $22K |
| MRNAModerna, Inc. | 372 | $19K |
| GMABGenmab A/S | 336 | $9K |
| OGNOrganon & Co. | 1,012 | $6K |
| JAZZJazz Pharmaceuticals plc | 32 | $6K |
| ADILADIAL PHARMACEUTICALS, INC. | 1,923 | $3K |
| INCYIncyte Corp. | 31 | $3K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 45 | $3K |
| LGNDLigand Pharmaceuticals Incorporated | 9 | $2K |
| APLSApellis Pharmaceuticals, Inc. | 28 | $1K |
| EXELEXELIXIS, INC. | 26 | $1K |
| TEVATeva Pharmaceutical Industries Limited | 28 | $844 |
| GRFSGrifols S.A. | 90 | $722 |
| DNLIDenali Therapeutics Inc. | 36 | $692 |
| AGIOAGIOS PHARMACEUTICALS, INC. | 16 | $542 |
| IONSIONIS PHARMACEUTICALS INC | 5 | $376 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.